Article Text
Therapeutics
Ramipril reduced mortality and cardiovascular morbidity in high risk adults
Statistics from Altmetric.com
Footnotes
-
Sources of funding: Medical Research Council of Canada; Hoechst-Marion Roussel; AstraZeneca; King Pharmaceuticals; Natural Source Vitamin E Association and Negma; Heart and Stroke Foundation of Ontario.
-
For correspondence: Dr S Yusuf, Canadian Cardiovascular Collaboration Project Office, Hamilton General Hospital, 237 Barton Street East, Hamilton, Ontario L8L 2X2, Canada. Fax +1 905 521 1166.
↵† The HOPE Study Investigators. Can J Cardiol 1996;12:127–37.